Patient review and registration program increases oversight of opioid prescription trends.
Laurie Toich, Assistant Editor
Advertisement
Articles by Laurie Toich, Assistant Editor
HDAC inhibitors in combination with immune-stimulating agents improve tumor response.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
4
Current and Emerging BCMAxCD3 Bispecifics
5
